OnabotulinumtoxinA is an effective minimally invasive option for patients with PP, as measured by both clinician- and patient-reported outcomes.

An increasing number of Americans stopped, modified, or struggled to pay for their health insurance following the end of federal subsidies.

The FDA withdrew a proposed rule from 2015 that would have banned minors from using tanning beds nationwide, despite known skin cancer risks.

Patients with alopecia areata who did not respond to initial treatment with a JAKi or who did not maintain response may respond to JAKi switching.

Female cancer patients have increased survival but also have a higher risk for serious and adverse side effects from cancer treatment compared with men, accordi ...

Vitamin D3 did not affect COVID-19-related health care outcomes at 4 weeks but may have contributed to a reduction in long COVID risk.